Pradžia › Intersticinės plaučių ligos
Intersticinės plaučių ligos klinikiniai tyrimai JAV ieško dalyvių
53 tyrimai dėl Intersticinės plaučių ligos ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- New York City, NY18 tyrimai
- Philadelphia, PA16 tyrimai
- Los Angeles, CA14 tyrimai
- Durham, NC13 tyrimai
- Kansas City, KS13 tyrimai
- Charleston, SC13 tyrimai
- Chicago, IL12 tyrimai
- Houston, TX12 tyrimai
- Ann Arbor, MI11 tyrimai
- Aurora, CO11 tyrimai
- Salt Lake City, UT9 tyrimai
- Phoenix, AZ9 tyrimai
- Boston, MA9 tyrimai
- Rochester, MN9 tyrimai
- Birmingham, AL9 tyrimai
- Dallas, TX9 tyrimai
- Orlando, FL9 tyrimai
- Cincinnati, OH8 tyrimai
- Tampa, FL8 tyrimai
- Minneapolis, MN8 tyrimai
- San Francisco, CA7 tyrimai
- Bend, OR7 tyrimai
- Richmond, VA6 tyrimai
- Washington, DC6 tyrimai
- Denver, CO6 tyrimai
- Indianapolis, IN6 tyrimai
- Gainesville, FL5 tyrimai
- Naples, FL5 tyrimai
- Jacksonville, FL5 tyrimai
- Columbus, OH5 tyrimai
- Oklahoma City, OK5 tyrimai
- Winston-Salem, NC5 tyrimai
- Albuquerque, NM5 tyrimai
- Cleveland, OH5 tyrimai
- Nashville, TN5 tyrimai
- Pittsburgh, PA5 tyrimai
- Scottsdale, AZ4 tyrimai
- Rochester, NY4 tyrimai
- New Haven, CT4 tyrimai
- Davie, FL4 tyrimai
Pagal valstiją
- Alabama9 tyrimai
- Arizona13 tyrimai
- Džordžija3 tyrimai
- Florida24 tyrimai
- Ilinoisas12 tyrimai
- Indianas6 tyrimai
- Kalifornija22 tyrimai
- Kanzasas13 tyrimai
- Kentukis4 tyrimai
- Koloradas15 tyrimai
- Kolumbijos apskritis5 tyrimai
- Konektikutas4 tyrimai
- Luiziana5 tyrimai
- Masčusetsas11 tyrimai
- Merilendas5 tyrimai
- Minesota14 tyrimai
- Misisipė3 tyrimai
- Misūris6 tyrimai
- Mičiganas16 tyrimai
- Nevada4 tyrimai
- New Jersey3 tyrimai
- New Mexico5 tyrimai
- New York20 tyrimai
- North Carolina18 tyrimai
- Ohio14 tyrimai
- Oklahoma5 tyrimai
- Oregon9 tyrimai
- Pennsylvania18 tyrimai
- South Carolina14 tyrimai
- Tennessee7 tyrimai
- Texas18 tyrimai
- Utah9 tyrimai
- Virginia8 tyrimai
- Wisconsin4 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Renkami dalyviai3 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-29 · NCT05798923Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07613099Pulmonary Fibrosis Foundation Community Registry
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT05382572A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07323732A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07816185SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT07269262A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT06572384Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Renkami dalyviai2 fazė
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Renkami dalyviai2 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07333183Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-27 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07486869PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-18 · NCT06855329Platform Clinical Study for Conquering Scleroderma
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-17 · NCT06328777Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Renkami dalyviai2 fazė
Amžius nuo 8 iki 60 · Visoms lytims · Atnaujinta 2026-08-14 · NCT03630211An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-13 · NCT07234032Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.